Custom Search

News

Monday 01 November 2004

Combination treatment of rituximab and imatinib mesylate for simultaneous relapse of MALT lymphoma and a gastrointestinal stromal tumor.

By: Bompas E, Velay B, Blay JY.

Leuk Lymphoma 2004 Nov;45(11):2353-4

A clinical case of patient with a simultaneous gastrointestinal stromal tumors (GIST) and MALT lymphoma in relapse is presented. Simultaneous treatment with imatinib mesylate and rituximab was given, yielded response for both tumors and was well tolerated.

Use of this site is subject to the following terms of use